Nevárez Andrea, Saftoiu A, Bhutani M S
Gastroenterology Unit, La Fe Hospital, Valencia, Spain.
Research Center of Gastroenterology and Hepatology Craiova, University of Medicine and Pharmacy Craiova, România.
Curr Health Sci J. 2011 Jan;37(1):31-4. Epub 2011 Mar 21.
Primary esophageal small cell carcinoma (SmCC) is a rare disease with a poor prognosis despite agressive multimodality combination treatment. This article presents the case of a 76-year old women diagnosed with pimary esophageal SmCC. The diagnosis was established by upper gastrointestinal endoscopy with biopsies that confirmed an esophageal SmCC positive to synaptophysin, chromogranin, CD56, TTF-1, and cytokeratin 8/18. Further staging procedures included CT, PET and EUS, followed by combination chemotherapy and radiotherapy. Restaging was then performed, again with PET and CT of the thorax, abdomen and pelvis. This was then followed by salvage esophagectomy due to the presence of residual tumor. Surgical pathology confirmed a 3 cm SmCC, with invasion of the submucosa and lymphovascular invasion. In conclusion, the article describes the rare occurrence of esophageal SmCC, together with the algorithm of diagnosis and staging based on state-of-the-art imaging methods. This was followed by combination chemoradiotherapy and surgical esophagectomy as the standard of care in this aggressive disease.
原发性食管小细胞癌(SmCC)是一种罕见疾病,尽管采用了积极的多模式联合治疗,其预后仍然很差。本文介绍了一例76岁女性被诊断为原发性食管SmCC的病例。通过上消化道内镜检查及活检确诊,活检证实食管SmCC对突触素、嗜铬粒蛋白、CD56、甲状腺转录因子-1和细胞角蛋白8/18呈阳性。进一步的分期检查包括CT、PET和超声内镜,随后进行联合化疗和放疗。然后再次进行分期,同样采用胸部、腹部和盆腔的PET和CT检查。由于存在残留肿瘤,随后进行了挽救性食管切除术。手术病理证实为3 cm的SmCC,侵犯黏膜下层并伴有脉管浸润。总之,本文描述了食管SmCC的罕见病例,以及基于先进成像方法的诊断和分期流程。随后,联合放化疗和手术食管切除术作为这种侵袭性疾病的标准治疗方法。